Hostname: page-component-77f85d65b8-6bnxx Total loading time: 0 Render date: 2026-04-13T16:58:24.984Z Has data issue: false hasContentIssue false
  • English
  • Français

BDNF-related mutations in major depressive disorder: a systematic review

Published online by Cambridge University Press:  22 August 2022

Johannes Hartig  and
Bogdan Nemeş Open the ORCID record for Bogdan Nemeş [Opens in a new window]
Johannes Hartig
Affiliation:
Department of Medical Psychology and Psychiatry, Iuliu Hatieganu University of Medicine and Pharmacy Cluj-Napoca, V. Babes St. No. 43, 400012 Cluj-Napoca, Romania Department of Neurology, University Hospital Wuerzburg, Josef-Schneider Street No. 11, 97080 Wuerzburg, Germany
Bogdan Nemeş*
Affiliation:
Department of Medical Psychology and Psychiatry, Iuliu Hatieganu University of Medicine and Pharmacy Cluj-Napoca, V. Babes St. No. 43, 400012 Cluj-Napoca, Romania
*
Author for correspondence: Bogdan Nemeş, Email: nemes.bogdan@umfcluj.ro
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

A better understanding of the genetic, molecular and cellular mechanisms of brain-derived neurotrophic factor (BDNF) and its association with neuroplasticity could play a pivotal role in finding future therapeutic targets for novel drugs in major depressive disorder (MDD). Because there are conflicting results regarding the exact role of BDNF polymorphisms in MDD still, we set out to systematically review the current evidence regarding BDNF-related mutations in MDD.

Methods:

We conducted a keyword-guided search of the PubMed and Embase databases, using ‘BDNF’ or ‘brain-derived neurotrophic factor’ and ‘major depressive disorder’ and ’single-nucleotide polymorphism’. We included all publications in line with our exclusion and inclusion criteria that focused on BDNF-related mutations in the context of MDD.

Results:

Our search yielded 427 records in total. After screening and application of our eligibility criteria, 71 studies were included in final analysis. According to present overall scientific data, there is a possibly major pathophysiological role for BDNF neurotrophic systems to play in MDD. However, on the one hand, the synthesis of evidence makes clear that likely no overall association of BDNF-related mutations with MDD exists. On the other hand, it can be appreciated that solidifying evidence emerged on specific significant sub-conditions and stratifications based on various demographic, clinico-phenotypical and neuromorphological variables.

Conclusions:

Further research should elucidate specific BDNF-MDD associations based on demographic, clinico-phenotypical and neuromorphological variables. Furthermore, biomarker approaches, specifically combinatory ones, involving BDNF should be further investigated.

Keywords

brain-derived neurotrophic factormajor depressive disordersingle-nucleotide polymorphismsneuroplasticitybiomarkers

Information

Type
Review Article
Information
Acta Neuropsychiatrica , Volume 35 , Issue 1 , February 2023 , pp. 5 - 26
Check for updates
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of Scandinavian College of Neuropsychopharmacology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Ai, M, Wang, J, Chen, J, Wang, W, Xu, X, Gan, Y, Li, X, Gou, X, Cao, J, Lv, Z, Chen, X, Wang, H, Ma, Q and Kuang, L (2019) Plasma brain-derived neurotrophic factor (BDNF) concentration and the BDNF Val66Met polymorphism in suicide: a prospective study in patients with depressive disorder. Pharmacogenomics and Personalized Medicine 12, 97–106. doi: 10.2147/PGPM.S201187.CrossRefGoogle ScholarPubMed
Akiskal, HS and Benazzi, F (2006) The DSM-IV and ICD-10 categories of recurrent [major] depressive and bipolar II disorders: evidence that they lie on a dimensional spectrum. Journal of Affective Disorders 92(1), 45–54. doi: 10.1016/j.jad.2005.12.035.CrossRefGoogle Scholar
Aldoghachi, AF, Tor, YS, Redzun, SZ, Lokman, KAB, Razaq, NAA, Shahbudin, AF, Badamasi, IM, Cheah, P-S, Stanslas, J, Veerakumarasivam, A, Rosli, R, Ibrahim, N, Lye, MS, Ling, K-H (2019) Screening of brain-derived neurotrophic factor (BDNF) single nucleotide polymorphisms and plasma BDNF levels among malaysian major depressive disorder patients. PLOS ONE 14(1), e0211241. doi: 10.1371/journal.pone.0211241.CrossRefGoogle ScholarPubMed
Alexopoulos, GS, Glatt, CE, Hoptman, MJ, Kanellopoulos, D, Murphy, CF, Kelly, RE, Morimoto, SS, Lim, KO and Gunning, FM (2010) BDNF Val66met polymorphism, white matter abnormalities and remission of geriatric depression. Journal of Affective Disorders 125(1-3), 262–268. doi: 10.1016/j.jad.2010.02.115.CrossRefGoogle ScholarPubMed
Angst, J and Merikangas, K (1997) The depressive spectrum: diagnostic classification and course. Journal of Affective Disorders 45(1-2), 31–39; discussion 39–40. doi: 10.1016/s0165-0327(97)00057-8.CrossRefGoogle ScholarPubMed
Anisman, H and Hayley, S (2012) Inflammatory factors contribute to depression and its comorbid conditions. Science Signaling 5(244). doi: 10.1126/scisignal.2003579.CrossRefGoogle ScholarPubMed
Autry, AE and Monteggia, LM (2012) Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacological Reviews 64(2), 238–258. doi: 10.1124/pr.111.005108.CrossRefGoogle ScholarPubMed
Benazzi, F (2006) The continuum/spectrum concept of mood disorders: is mixed depression the basic link? European Archives of Psychiatry and Clinical Neuroscience 256(8), 512–515. doi: 10.1007/s00406-006-0672-4.CrossRefGoogle ScholarPubMed
Berrocal, C, Ruiz Moreno, MA, Rando, MA, Benvenuti, A and Cassano, GB (2008) Borderline personality disorder and mood spectrum. Psychiatry Research 159(3), 300–307. doi: 10.1016/j.psychres.2007.10.002.CrossRefGoogle ScholarPubMed
Bîlc, MI, Vulturar, R, Chiş, A, Buciuman, M, Nuţu, D, Bunea, I, Szentágotai-Tătar, A and Miu, AC (2018) Childhood trauma and emotion regulation: the moderator role of BDNF Val66Met. Neuroscience Letters 685, 7–11. doi: 10.1016/j.neulet.2018.07.018.CrossRefGoogle ScholarPubMed
Björkholm, C and Monteggia, LM (2016) BDNF – a key transducer of antidepressant effects. Neuropharmacology 102(7), 72–79. doi: 10.1016/j.neuropharm.2015.10.034.CrossRefGoogle ScholarPubMed
Brunoni, AR, Carracedo, A, Amigo, OM, Pellicer, AL, Talib, L, Carvalho, AF, Lotufo, PA, Benseñor, IM, Gattaz, W, Cappi, C (2020) Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial. Brazilian Journal of Psychiatry 42(2), 128–135. doi: 10.1590/1516-4446-2019-0620.CrossRefGoogle ScholarPubMed
Brunoni, AR, Kemp, AH, Shiozawa, P, Cordeiro, Q, Valiengo, LCL, Goulart, AC, Coprerski, B, Lotufo, PA, Brunoni, D, Perez, ABA, Fregni, F, Benseñor, IM (2013) Impact of 5-HTTLPR and BDNF polymorphisms on response to sertraline versus transcranial direct current stimulation: implications for the serotonergic system. European Neuropsychopharmacology 23(11), 1530–1540. doi: 10.1016/j.euroneuro.2013.03.009.CrossRefGoogle ScholarPubMed
Caldieraro, MA, McKee, M, Leistner-Segal, S, Vares, EA, Kubaski, F, Spanemberg, L, Brusius-Facchin, AC, Fleck, MP and Mischoulon, D (2018) Val66Met polymorphism association with serum BDNF and inflammatory biomarkers in major depression. The World Journal of Biological Psychiatry 19(5), 402–409. doi: 10.1080/15622975.2017.1347713.CrossRefGoogle ScholarPubMed
Cao, B, Bauer, IE, Sharma, AN, Mwangi, B, Frazier, T, Lavagnino, L, Zunta-Soares, GB, Walss-Bass, C, Glahn, DC, Kapczinski, F, Nielsen, DA, Soares, JC (2016) Reduced hippocampus volume and memory performance in bipolar disorder patients carrying the BDNF val66met met allele. Journal of Affective Disorders 198, 198–205. doi: 10.1016/j.jad.2016.03.044.CrossRefGoogle ScholarPubMed
Carballedo, A, Amico, F, Ugwu, I, Fagan, AJ, Fahey, C, Morris, D, Meaney, JF, Leemans, A and Frodl, T (2012) Reduced fractional anisotropy in the uncinate fasciculus in patients with major depression carrying the met-allele of the Val66Met brain-derived neurotrophic factor genotype. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 159B(5), 537–548. doi: 10.1002/ajmg.b.32060.CrossRefGoogle ScholarPubMed
Carballedo, A, Morris, D, Zill, P, Fahey, C, Reinhold, E, Meisenzahl, E, Bondy, B, Gill, M, Möller, HJ, Frodl, T (2013) Brain-derived neurotrophic factor Val66Met polymorphism and early life adversity affect hippocampal volume. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics: the Official Publication of the International Society of Psychiatric Genetics 162B(2), 183–190. doi: 10.1002/ajmg.b.32130.CrossRefGoogle ScholarPubMed
Cardoner, N, Soria, V, Gratacòs, M, Hernández-Ribas, R, Pujol, J, López-Solà, M, Deus, J, Urretavizcaya, M, Estivill, X, Menchón, JM, Soriano-Mas, C (2013) VAL66MET BDNF genotypes in melancholic depression: effects on brain structure and treatment outcome: research article: brain structure and BDNF genotypes in melancholia. Depression and Anxiety 30(3), 225–233. doi: 10.1002/da.22025.CrossRefGoogle Scholar
Cargill, M, Altshuler, D, Ireland, J, Sklar, P, Ardlie, K, Patil, N, Lane, CR, Lim, EP, Kalyanaraman, N, Nemesh, J, Ziaugra, L, Friedland, L, Rolfe, A, Warrington, J, Lipshutz, R, Daley, GQ, Lander, ES (1999) Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nature Genetics 22(3), 231–238. doi: 10.1038/10290.CrossRefGoogle ScholarPubMed
Carlberg, L, Scheibelreiter, J, Hassler, MR, Schloegelhofer, M, Schmoeger, M, Ludwig, B, Kasper, S, Aschauer, H, Egger, G, Schosser, A (2014) Brain-derived neurotrophic factor (BDNF)—epigenetic regulation in unipolar and bipolar affective disorder. Journal of Affective Disorders 168(2), 399–406. doi: 10.1016/j.jad.2014.07.022.CrossRefGoogle ScholarPubMed
Caruso, R, Nanni, MG, Riba, M, Sabato, S, Mitchell, AJ, Croce, E and Grassi, L (2017) Depressive spectrum disorders in cancer: prevalence, risk factors and screening for depression: a critical review. Acta Oncologica 56(2), 146–155. doi: 10.1080/0284186X.2016.1266090.CrossRefGoogle ScholarPubMed
Castrén, E (2005) Is mood chemistry? Nature Reviews Neuroscience 6(3), 241–246. doi: 10.1038/nrn1629.CrossRefGoogle ScholarPubMed
Chen, J, Zhao, L, Liu, Y, Fan, S and Xie, P (2017b) Comparative efficacy and acceptability of electroconvulsive therapy versus repetitive transcranial magnetic stimulation for major depression: a systematic review and multiple-treatments meta-analysis. Behavioural Brain Research 320(9373), 30–36. doi: 10.1016/j.bbr.2016.11.028.CrossRefGoogle ScholarPubMed
Chen, L, Lawlor, DA, Lewis, SJ, Yuan, W, Abdollahi, MR, Timpson, NJ, Day, IN, Ebrahim, S, Smith, GD, Shugart, YY (2008) Genetic association study of BDNF in depression: finding from two cohort studies and a meta-analysis. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics: the Official Publication of the International Society of Psychiatric Genetics 147B(6), 814–821. doi: 10.1002/ajmg.b.30686.CrossRefGoogle ScholarPubMed
Chen, M-H, Kao, C-F, Tsai, S-J, Li, C-T, Lin, W-C, Hong, C-J, Bai, Y-M, Tu, P-C and Su, T-P (2021a) Treatment response to low-dose ketamine infusion for treatment-resistant depression: a gene-based genome-wide association study. Genomics 113(2), 507–514. doi: 10.1016/j.ygeno.2020.12.030.CrossRefGoogle ScholarPubMed
Chen, M-H, Lin, W-C, Tsai, S-J, Li, C-T, Cheng, C-M, Wu, H-J, Bai, Y-M, Hong, C-J, Tu, P-C, Su, T-P (2021b) Effects of treatment refractoriness and brain-derived neurotrophic factor Val66Met polymorphism on antidepressant response to low-dose ketamine infusion. European Archives of Psychiatry and Clinical Neuroscience 271(7), 1267–1274. doi: 10.1007/s00406-021-01264-w.CrossRefGoogle ScholarPubMed
Chen, M-H, Lin, W-C, Wu, H-J, Cheng, C-M, Li, C-T, Hong, C-J, Tu, P-C, Bai, Y-M, Tsai, S-J, Su, T-P (2019) Antisuicidal effect, BDNF Val66Met polymorphism, and low-dose ketamine infusion: reanalysis of adjunctive ketamine study of Taiwanese patients with treatment-resistant depression (AKSTP-TRD). Journal of Affective Disorders 251, 162–169. doi: 10.1016/j.jad.2019.03.075.CrossRefGoogle ScholarPubMed
Chen, S-D, Wu, C-L, Hwang, W-C and Yang, D-I (2017a) More insight into BDNF against neurodegeneration: anti-apoptosis, anti-oxidation, and suppression of autophagy. International Journal of Molecular Sciences 18(3), 545. doi: 10.3390/ijms18030545.CrossRefGoogle ScholarPubMed
Chi, MH, Chang, HH, Lee, S-Y, Lee, IH, Gean, PW, Yang, YK, Lu, R-B and Chen, PS (2010) Brain derived neurotrophic factor gene polymorphism (Val66Met) and short-term antidepressant response in major depressive disorder. Journal of Affective Disorders 126(3), 430–435. doi: 10.1016/j.jad.2010.07.006.CrossRefGoogle ScholarPubMed
Chi, MH, Lee, S-Y, Chang, H-H, Yang, Y-K, Lin, E and Chen, P-S (2011) Comparison of antidepressant efficacy-related SNPs among taiwanese and four populations in the HapMap database. Journal of the Formosan Medical Association 110(7), 478–482. doi: 10.1016/s0929-6646(11)60071-5.CrossRefGoogle ScholarPubMed
Choi, M-J, Kang, R-H, Lim, S-W, Oh, K-S and Lee, M-S (2006) Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder. Brain Research 1118(1), 176–182. doi: 10.1016/j.brainres.2006.08.012.CrossRefGoogle ScholarPubMed
Cipriani, A, Furukawa, TA, Salanti, G, Chaimani, A, Atkinson, LZ, Ogawa, Y, Leucht, S, Ruhe, HG, Turner, EH, Higgins, JPT, Egger, M, Takeshima, N, Hayasaka, Y, Imai, H, Shinohara, K, Tajika, A, Ioannidis, JPA, Geddes, JR (2018) Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. The Lancet 391(10128), 1357–1366. doi: 10.1016/S0140-6736(17)32802-7.CrossRefGoogle ScholarPubMed
Cole, J, Weinberger, DR, Mattay, VS, Cheng, X, Toga, AW, Thompson, PM, Powell-Smith, G, Cohen-Woods, S, Simmons, A, McGuffin, P, Fu, CHY (2011) No effect of 5HTTLPR or BDNF Val66Met polymorphism on hippocampal morphology in major depression. Genes, Brain and Behavior 10(7), 756–764. doi: 10.1111/j.1601-183X.2011.00714.x.CrossRefGoogle ScholarPubMed
Colle, R, Deflesselle, E, Martin, S, David, DJ, Hardy, P, Taranu, A, Falissard, B, Verstuyft, C and Corruble, E (2015a) BDNF/TRKB/P75NTR polymorphisms and their consequences on antidepressant efficacy in depressed patients. Pharmacogenomics 16(9), 997–1013. doi: 10.2217/pgs.15.56.CrossRefGoogle ScholarPubMed
Colle, R, Gressier, F, Verstuyft, C, Deflesselle, E, Lépine, J-P, Ferreri, F, Hardy, P, Guilloux, J-P, Petit, A-C, Fève, B, Falissard, B, Becquemont, L, Corruble, E (2015b) Brain-derived neurotrophic factor Val66Met polymorphism and 6-month antidepressant remission in depressed Caucasian patients. Journal of Affective Disorders 175(66), 233–240. doi: 10.1016/j.jad.2015.01.013.CrossRefGoogle ScholarPubMed
Colle, R, Trabado, S, David, DJ, Brailly-Tabard, S, Hardy, P, Falissard, B, Fève, B, Becquemont, L, Verstuyft, C, Corruble, E (2017) Plasma BDNF level in major depression: biomarker of the Val66Met BDNF polymorphism and of the clinical course in met carrier patients. Neuropsychobiology 75(1), 39–45. doi: 10.1159/000478862.CrossRefGoogle ScholarPubMed
Costache, A, Riza, AL, Popescu, M, Streaţă, I, Dincă, ME, Glăvan, DG, Vladu, IM, Udriştoiu, I and Ioana, M (2021) Association between genetic variants and depression in a Romanian cohort. Romanian Journal of Morphology and Embryology 62(2), 491–496. doi: 10.47162/RJME.62.2.15.CrossRefGoogle Scholar
Czira, ME, Wersching, H, Baune, BT and Berger, K (2012) Brain-derived neurotrophic factor gene polymorphisms, neurotransmitter levels, and depressive symptoms in an elderly population. AGE 34(6), 1529–1541. doi: 10.1007/s11357-011-9313-6.CrossRefGoogle Scholar
De Oliveira, CCS, Pereira, GRC, De Alcantara, JYS, Antunes, D, Caffarena, ER and De Mesquita, JF (2019) In silico analysis of the V66M variant of human BDNF in psychiatric disorders: an approach to precision medicine. PLOS ONE 14(4), e0215508. doi: 10.1371/journal.pone.0215508.CrossRefGoogle ScholarPubMed
Deflesselle, E, Verstuyft, C, Petit, AC, Hardy, P, David, DJ, Falissard, B, Fève, B, Rigal, L, Becquemont, L, Corruble, E, Colle, R (2017) No impact of eight NTRK2 genetic polymorphisms on 6-month antidepressant efficacy in depressed patients. Pharmacogenomics 18(4), 349–357. doi: 10.2217/pgs-2016-0165.CrossRefGoogle ScholarPubMed
Deflesselle, E, Colle, R, Rigal, L, David, DJ, Vievard, A, Martin, S, Becquemont, L, Verstuyft, C and Corruble, E (2018) The TRKB rs2289656 genetic polymorphism is associated with acute suicide attempts in depressed patients: a transversal case control study. PLOS ONE 13(10), e0205648. doi: 10.1371/journal.pone.0205648.CrossRefGoogle ScholarPubMed
Deuschle, M, Gilles, M, Scharnholz, B, Lederbogen, F, Lang, U and Hellweg, R (2012) Changes of serum concentrations of brain-derived neurotrophic factor (BDNF) during treatment with venlafaxine and mirtazapine: role of medication and response to treatment. Pharmacopsychiatry 46(02), 54–58. doi: 10.1055/s-0032-1321908.Google ScholarPubMed
Devlin, P, Cao, X and Stanfill, AG (2021) Genotype-expression interactions for BDNF across human brain regions. BMC Genomics 22(1), 207. doi: 10.1186/s12864-021-07525-1.CrossRefGoogle ScholarPubMed
Domschke, K, Lawford, B, Laje, G, Berger, K, Young, R, Morris, P, Deckert, J, Arolt, V, McMahon, FJ, Baune, BT (2010) Brain-derived neurotrophic factor (BDNF) gene: no major impact on antidepressant treatment response. The International Journal of Neuropsychopharmacology 13(01), 93. doi: 10.1017/S1461145709000030.CrossRefGoogle ScholarPubMed
Dong, C, Wong, M-L and Licinio, J (2009) Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans. Molecular Psychiatry 14(12), 1105–1118. doi: 10.1038/mp.2009.92.CrossRefGoogle ScholarPubMed
Dowlati, Y, Herrmann, N, Swardfager, W, Liu, H, Sham, L, Reim, EK and Lanctôt, KL (2010) A meta-analysis of cytokines in major depression. Biological Psychiatry 67(5), 446–457. doi: 10.1016/j.biopsych.2009.09.033.CrossRefGoogle ScholarPubMed
Dunham, JS, Deakin, JFW, Miyajima, F, Payton, A and Toro, CT (2009) Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains. Journal of Psychiatric Research 43(14), 1175–1184. doi: 10.1016/j.jpsychires.2009.03.008.CrossRefGoogle ScholarPubMed
Dwivedi, Y, Rizavi, HS, Conley, RR, Roberts, RC, Tamminga, CA and Pandey, GN (2003) Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Archives of General Psychiatry 60(8), 804. doi: 10.1001/archpsyc.60.8.804.CrossRefGoogle ScholarPubMed
Elfving, B, Buttenschøn, HN, Foldager, L, Poulsen, PHP, Andersen, JH, Grynderup, MB, Hansen, Å.M, Kolstad, HA, Kaerlev, L, Mikkelsen, S, Thomsen, JF, Børglum, AD, Wegener, G, Mors, O (2012) Depression, the Val66Met polymorphism, age, and gender influence the serum BDNF level. Journal of Psychiatric Research 46(9), 1118–1125. doi: 10.1016/j.jpsychires.2012.05.003.CrossRefGoogle ScholarPubMed
Evinova, A, Babusikova, E, Straka, S, Ondrejka, I and Lehotsky, J (2012) Analysis of genetic polymorphisms of brain-derived neurotrophic factor and methylenetetrahydrofolate reductase in depressed patients in a Slovak (Caucasian) population. General Physiology and Biophysics 31(4), 415–422. doi: 10.4149/gpb_2012_049.CrossRefGoogle Scholar
Fabbri, C, Marsano, A, Albani, D, Chierchia, A, Calati, R, Drago, A, Crisafulli, C, Calabrò, M, Kasper, S, Lanzenberger, R, Zohar, J, Juven-Wetzler, A, Souery, D, Montgomery, S, Mendlewicz, J, Serretti, A (2014) PPP3CC gene: a putative modulator of antidepressant response through the B-cell receptor signaling pathway. The Pharmacogenomics Journal 14(5), 463–472. doi: 10.1038/tpj.2014.15.CrossRefGoogle ScholarPubMed
Fabbri, C, Crisafulli, C, Calati, R, Albani, D, Forloni, G, Calabrò, M, Martines, R, Kasper, S, Zohar, J, Juven-Wetzler, A, Souery, D, Montgomery, S, Mendlewicz, J, Serretti, A (2017) Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance. European Archives of Psychiatry and Clinical Neuroscience 267(8), 723–735. doi: 10.1007/s00406-017-0766-1.CrossRefGoogle ScholarPubMed
Ferreira Fratelli, C, Willatan Siqueira, J, Rodrigues Gontijo, B, de Lima Santos, M, de Souza Silva, CM and Rodrigues da Silva, IC (2021) BDNF genetic variant and its genotypic fluctuation in major depressive disorder. Behavioural Neurology 2021(1), 7117613–16. doi: 10.1155/2021/7117613.CrossRefGoogle ScholarPubMed
Ferrer, A, Labad, J, Salvat-Pujol, N, Barrachina, M, Costas, J, Urretavizcaya, M, de Arriba-Arnau, A, Crespo, Jé M, Soriano-Mas, C, Carracedo, Ángel, Menchón, Jé M, Soria, V (2019) BDNF genetic variants and methylation: effects on cognition in major depressive disorder. Translational Psychiatry 9(1), 265. doi: 10.1038/s41398-019-0601-8.CrossRefGoogle ScholarPubMed
Frodl, T, Schüle, C, Schmitt, G, Born, C, Baghai, T, Zill, P, Bottlender, R, Rupprecht, R, Bondy, B, Reiser, M, Möller, H-J, Meisenzahl, EM (2007) Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Archives of General Psychiatry 64(4), 410. doi: 10.1001/archpsyc.64.4.410.CrossRefGoogle ScholarPubMed
Frodl, T, Skokauskas, N, Frey, E-M, Morris, D, Gill, M and Carballedo, A (2014) BDNFVal66Met genotype interacts with childhood adversity and influences the formation of hippocampal subfields: Hippocampal subfields and stress x gene interaction. Human Brain Mapping 35(12), 5776–5783. doi: 10.1002/hbm.22584.CrossRefGoogle Scholar
Froud, A, Murphy, J, Cribb, L, Ng, CH and Sarris, J (2019) The relationship between dietary quality, serum brain-derived neurotrophic factor (BDNF) level, and the Val66met polymorphism in predicting depression. Nutritional Neuroscience 22(7), 513–521. doi: 10.1080/1028415X.2017.1415281.CrossRefGoogle ScholarPubMed
Fuchikami, M, Morinobu, S, Segawa, M, Okamoto, Y, Yamawaki, S, Ozaki, N, Inoue, T, Kusumi, I, Koyama, T, Tsuchiyama, K, Terao, T (2011) DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression. PLoS ONE 6(8), e23881. doi: 10.1371/journal.pone.0023881.CrossRefGoogle ScholarPubMed
Gonul, AS, Akdeniz, F, Taneli, F, Donat, O, Eker, Ç. and Vahip, S (2005) Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. European Archives of Psychiatry and Clinical Neuroscience 255(6), 381–386. doi: 10.1007/s00406-005-0578-6.CrossRefGoogle ScholarPubMed
Gratacòs, M, González, JR, Mercader, JM, de Cid, R, Urretavizcaya, M and Estivill, X (2007) Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biological Psychiatry 61(7), 911–922. doi: 10.1016/j.biopsych.2006.08.025.CrossRefGoogle ScholarPubMed
Gratacòs, M, Soria, V, Urretavizcaya, M, González, JR, Crespo, JM, Bayés, M, de Cid, R, Menchón, JM, Vallejo, J, Estivill, X (2008) A brain-derived neurotrophic factor (BDNF) haplotype is associated with antidepressant treatment outcome in mood disorders. The Pharmacogenomics Journal 8(2), 101–112. doi: 10.1038/sj.tpj.6500460.CrossRefGoogle ScholarPubMed
Groves, JO (2007) Is it time to reassess the BDNF hypothesis of depression? Molecular Psychiatry 12(12), 1079–1088. doi: 10.1038/sj.mp.4002075.CrossRefGoogle ScholarPubMed
Gyekis, JP, Yu, W, Dong, S, Wang, H, Qian, J, Kota, P and Yang, J (2013) No association of genetic variants in BDNF with major depression: a meta- and gene-based analysis. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 162(1), 61–70. doi: 10.1002/ajmg.b.32122.CrossRefGoogle Scholar
Hajek, T, Kopecek, M and Höschl, C (2012) Reduced hippocampal volumes in healthy carriers of brain-derived neurotrophic factor Val66Met polymorphism: meta-analysis. The World Journal of Biological Psychiatry: the Official Journal of the World Federation of Societies of Biological Psychiatry 13(3), 178–187. doi: 10.3109/15622975.2011.580005.CrossRefGoogle ScholarPubMed
Sharma, A, Meresh, ES, Ghanshyam, P, Kang, R, Hage, O, Garlenski, B and Sinacore, JM (2015) Serum BDNF: a potential biomarker for major depressive disorder and antidepressant response prediction. Journal of Depression & Anxiety 4(02), 1–8. doi: 10.4172/2167-1044.1000179.Google Scholar
Hariri, AR, Goldberg, TE, Mattay, VS, Kolachana, BS, Callicott, JH, Egan, MF and Weinberger, DR (2003) Brain-derived neurotrophic factor val 66 met polymorphism affects human memory-related hippocampal activity and predicts memory performance. The Journal of Neuroscience 23(17), 6690–6694. doi: 10.1523/JNEUROSCI.23-17-06690.2003.CrossRefGoogle Scholar
Harrisberger, F, Smieskova, R, Schmidt, A, Lenz, C, Walter, A, Wittfeld, K, Grabe, HJ, Lang, UE, Fusar-Poli, P, Borgwardt, S (2015) BDNF Val66Met polymorphism and hippocampal volume in neuropsychiatric disorders: a systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews 55(June), 107–118. doi: 10.1016/j.neubiorev.2015.04.017.CrossRefGoogle ScholarPubMed
Harrisberger, F, Spalek, K, Smieskova, R, Schmidt, A, Coynel, D, Milnik, A, Fastenrath, M, Freytag, V, Gschwind, L, Walter, A, Vogel, T, Bendfeldt, K, de Quervain, DJ-F, Papassotiropoulos, A, Borgwardt, S (2014) The association of the BDNF Val66Met polymorphism and the hippocampal volumes in healthy humans: a joint meta-analysis of published and new data. Neuroscience & Biobehavioral Reviews 42, 267–278. doi: 10.1016/j.neubiorev.2014.03.011.CrossRefGoogle ScholarPubMed
Hennings, JM, Kohli, MA, Uhr, M, Holsboer, F, Ising, M and Lucae, S (2019) Polymorphisms in the BDNF and BDNFOS genes are associated with hypothalamus-pituitary axis regulation in major depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 95(4), 109686. doi: 10.1016/j.pnpbp.2019.109686.CrossRefGoogle ScholarPubMed
Hing, B, Davidson, S, Lear, M, Breen, G, Quinn, J, McGuffin, P and MacKenzie, A (2012) A polymorphism associated with depressive disorders differentially regulates brain derived neurotrophic factor promoter IV activity. Biological Psychiatry 71(7), 618–626. doi: 10.1016/j.biopsych.2011.11.030.CrossRefGoogle ScholarPubMed
Hing, B, Sathyaputri, L and Potash, JB (2018) A comprehensive review of genetic and epigenetic mechanisms that regulate BDNF expression and function with relevance to major depressive disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 177(2), 143–167. doi: 10.1002/ajmg.b.32616.CrossRefGoogle ScholarPubMed
Hong, C-J, Huo, S-J, Yen, F-C, Tung, C-L, Pan, G-M and Tsai, S-J (2003) Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior. Neuropsychobiology 48(4), 186–189. doi: 10.1159/000074636.CrossRefGoogle ScholarPubMed
Hosang, GM, Shiles, C, Tansey, KE, McGuffin, P and Uher, R (2014) Interaction between stress and the BDNFVal66Met polymorphism in depression: a systematic review and meta-analysis. BMC Medicine 12(1), 7. doi: 10.1186/1741-7015-12-7.CrossRefGoogle Scholar
Howick, J, Chalmers, I, Glasziou, P, Greenhalgh, T, Heneghan, C, Liberati, A, Moschetti, I, Phillips, B and Thornton, H, Explanation of the 2011 Oxford Centre for Evidence-Based Medicine (OCEBM) Levels of Evidence (Background Document), Oxford Centre for Evidence-Based Medicine, Available at https://www.cebm.ox.ac.uk/resources/levels-of-evidence/explanation-of-the-2011-ocebm-levels-of-evidence/, Accessed 2 December 2021,Google Scholar
Hsieh, M-T, Lin, C-C, Lee, C-T and Huang, T-L (2019) Abnormal brain-derived neurotrophic factor exon IX promoter methylation, protein, and mRNA levels in patients with major depressive disorder. Journal of Clinical Medicine 8(5), 568. doi: 10.3390/jcm8050568.CrossRefGoogle ScholarPubMed
Huang, T-L, Lee, C-T and Liu, Y-L (2008) Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants. Journal of Psychiatric Research 42(7), 521–525. doi: 10.1016/j.jpsychires.2007.05.007.CrossRefGoogle ScholarPubMed
Hwang, J-P, Tsai, S-J, Hong, C-J, Yang, C-H, Lirng, J-F and Yang, Y-M (2006) The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression. Neurobiology of Aging 27(12), 1834–1837. doi: 10.1016/j.neurobiolaging.2005.10.013.CrossRefGoogle ScholarPubMed
Ide, S, Kakeda, S, Watanabe, K, Yoshimura, R, Abe, O, Hayashi, K, Ueda, I, Kishi, T, Katsuki, A, Umene-Nakano, W, Iwata, N, Nakamura, J, Korogi, Y (2015) Relationship between a BDNF gene polymorphism and the brain volume in treatment-naive patients with major depressive disorder: a VBM analysis of brain MRI. Psychiatry Research: Neuroimaging 233(2), 120–124. doi: 10.1016/j.pscychresns.2015.05.016.CrossRefGoogle ScholarPubMed
Illi, A, Viikki, M, Poutanen, O, Setälä-Soikkeli, E, Nuolivirta, T, Kampman, O, Leinonen, E, Huhtala, H, Mononen, N, Lehtimäki, T (2013) No support for a role for BDNF gene polymorphisms rs11030101 and rs61888800 in major depressive disorder or antidepressant response in patients of Finnish origin. Psychiatric Genetics 23(1), 33–35. doi: 10.1097/YPG.0b013e3283586308.CrossRefGoogle ScholarPubMed
Itoh, K, Hashimoto, K, Kumakiri, C, Shimizu, E and Iyo, M (2004) Association between brain-derived neurotrophic factor 196 G/A polymorphism and personality traits in healthy subjects. American Journal of Medical Genetics 124B(1), 61–63. doi: 10.1002/ajmg.b.20078.CrossRefGoogle ScholarPubMed
Januar, V, Ancelin, M-L, Ritchie, K, Saffery, R and Ryan, J (2015) BDNF promoter methylation and genetic variation in late-life depression. Translational Psychiatry 5(8), e619. doi: 10.1038/tp.2015.114.CrossRefGoogle ScholarPubMed
Jessen, F, Schuhmacher, A, von Widdern, O, Guttenthaler, V, Hofels, S, Suliman, H, Scheef, L, Block, W, Urbach, H, Maier, W, Zobel, A (2009) No association of the Val66Met polymorphism of the brain-derived neurotrophic factor with hippocampal volume in major depression. Psychiatric Genetics 19(2), 99–101. doi: 10.1097/YPG.0b013e32832080ce.CrossRefGoogle ScholarPubMed
Juhasz, G, Dunham, JS, McKie, S, Thomas, E, Downey, D, Chase, D, Lloyd-Williams, K, Toth, ZG, Platt, H, Mekli, K, Payton, A, Elliott, R, Williams, SR, Anderson, IM, Deakin, JFW (2011) The CREB1-BDNF-NTRK2 pathway in depression: multiple gene-cognition-environment interactions. Biological Psychiatry 69(8), 762–771. doi: 10.1016/j.biopsych.2010.11.019.CrossRefGoogle ScholarPubMed
Kanellopoulos, D, Gunning, FM, Morimoto, SS, Hoptman, MJ, Murphy, CF, Kelly, RE, Glatt, C, Lim, KO and Alexopoulos, GS (2011) Hippocampal volumes and the brain-derived neurotrophic factor val66met polymorphism in geriatric major depression. The American Journal of Geriatric Psychiatry 19(1), 13–22. doi: 10.1097/JGP.0b013e3181f61d62.CrossRefGoogle ScholarPubMed
Kang, H-J, Bae, K-Y, Kim, S-W, Shin, I-S, Hong, YJ, Ahn, Y, Jeong, MH, Yoon, J-S and Kim, J-M (2016) BDNF val66met polymorphism and depressive disorders in patients with acute coronary syndrome. Journal of Affective Disorders 194, 1–8. doi: 10.1016/j.jad.2016.01.033.CrossRefGoogle ScholarPubMed
Kato, M, Serretti, A, Nonen, S, Takekita, Y, Wakeno, M, Azuma, J and Kinoshita, T (2015) Genetic variants in combination with early partial improvement as a clinical utility predictor of treatment outcome in major depressive disorder: the result of two pooled RCTs. Translational Psychiatry 5(2), e513. doi: 10.1038/tp.2015.6.CrossRefGoogle ScholarPubMed
Kautzky, A, Baldinger, P, Souery, D, Montgomery, S, Mendlewicz, J, Zohar, J, Serretti, A, Lanzenberger, R and Kasper, S (2015) The combined effect of genetic polymorphisms and clinical parameters on treatment outcome in treatment-resistant depression. European Neuropsychopharmacology 25(4), 441–453. doi: 10.1016/j.euroneuro.2015.01.001.CrossRefGoogle ScholarPubMed
Kim, JM, Stewart, R, Kang, HJ, Bae, KY, Kim, SW, Shin, IS, Hong, YJ, Ahn, Y, Jeong, MH, Yoon, JS (2015) BDNF methylation and depressive disorder in acute coronary syndrome: the K-DEPACS and EsDEPACS studies. Psychoneuroendocrinology 62(Suppl. 20), 159–165. doi: 10.1016/j.psyneuen.2015.08.013.CrossRefGoogle ScholarPubMed
Kim, SJ, Cho, S-J, Jang, HM, Shin, J, Park, P-W, Lee, YJ, Cho, IH, Choi, J-E and Lee, H-J (2010) Interaction between brain-derived neurotrophic factor Val66Met polymorphism and recent negative stressor in harm avoidance. Neuropsychobiology 61(1), 19–26. doi: 10.1159/000258639.CrossRefGoogle ScholarPubMed
Kim, Y-K, Ham, B-J and Han, K-M (2019) Interactive effects of genetic polymorphisms and childhood adversity on brain morphologic changes in depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 91(Suppl. 1), 4–13. doi: 10.1016/j.pnpbp.2018.03.009.CrossRefGoogle ScholarPubMed
Kishi, T, Yoshimura, R, Ikuta, T and Iwata, N (2018) Brain-derived neurotrophic factor and major depressive disorder: evidence from meta-analyses. Frontiers in Psychiatry 8, 308. doi: 10.3389/fpsyt.2017.00308.CrossRefGoogle ScholarPubMed
Kocabas, NA, Antonijevic, I, Faghel, C, Forray, C, Kasper, S, Lecrubier, Y, Linotte, S, Massat, I, Mendlewicz, J, Noro, M, Montgomery, S, Oswald, P, Snyder, L, Zohar, J, Souery, D (2011) Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder. International Clinical Psychopharmacology 26(1), 1–10. doi: 10.1097/YIC.0b013e32833d18f8.CrossRefGoogle ScholarPubMed
Kojima, M and Mizui, T (2017) BDNF Propeptide, Vitamins and Hormones (Vol. 104. Elsevier, pp. 19–28). doi: 10.1016/bs.vh.2016.11.006.Google Scholar
Kostic, M, Canu, E, Agosta, F, Munjiza, A, Novakovic, I, Dobricic, V, Maria Ferraro, P, Miler Jerkovic, V, Pekmezovic, T, Lecic Tosevski, D, Filippi, M (2016) The cumulative effect of genetic polymorphisms on depression and brain structural integrity: multigene effect and brain integrity in MDD. Human Brain Mapping 37(6), 2173–2184. doi: 10.1002/hbm.23165.CrossRefGoogle Scholar
Kreinin, A, Lisson, S, Nesher, E, Schneider, J, Bergman, J, Farhat, K, Lejbkowicz, F, Yadid, G, Raskin, L, Koman, I and Pinhasov, A (2015) Blood BDNF level is gender specific in severe depression. PLOS ONE 10(5), e0127643. doi: 10.1371/journal.pone.0127643,,CrossRefGoogle ScholarPubMed
Krogh, J, Rostrup, E, Thomsen, C, Elfving, B, Videbech, P and Nordentoft, M (2014) The effect of exercise on hippocampal volume and neurotrophines in patients with major depression-a randomized clinical trial. Journal of Affective Disorders 165(3), 24–30. doi: 10.1016/j.jad.2014.04.041.CrossRefGoogle ScholarPubMed
Laje, G, Lally, N, Mathews, D, Brutsche, N, Chemerinski, A, Akula, N, Kelmendi, B, Simen, A, McMahon, FJ, Sanacora, G, Zarate, C (2012) Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients. Biological Psychiatry 72(11), e27–e28. doi: 10.1016/j.biopsych.2012.05.031.CrossRefGoogle ScholarPubMed
Lan, MJ, Ogden, RT, Huang, Y, Oquendo, MA, Sullivan, GM, Miller, J, Milak, M, Mann, JJ and Parsey, RV (2014) Genetic variation in brain-derived neurotrophic factor val66met allele is associated with altered serotonin-1A receptor binding in human brain. NeuroImage 94(4), 33–39. doi: 10.1016/j.neuroimage.2014.02.027.CrossRefGoogle ScholarPubMed
Lau, J, Ioannidis, JP, Terrin, N, Schmid, CH and Olkin, I (2006) The case of the misleading funnel plot. BMJ (Clinical Research ed.) 333(7568), 597–600. doi: 10.1136/bmj.333.7568.597.CrossRefGoogle ScholarPubMed
Legge, RM, Sendi, S, Cole, JH, Cohen-Woods, S, Costafreda, SG, Simmons, A, Farmer, AE, Aitchison, KJ, McGuffin, P, Fu, CHY (2015) Modulatory effects of brain-derived neurotrophic factor Val66Met polymorphism on prefrontal regions in major depressive disorder. British Journal of Psychiatry 206(5), 379–384. doi: 10.1192/bjp.bp.113.143529.CrossRefGoogle ScholarPubMed
Lewis, CM, Ng, MY, Butler, AW, Cohen-Woods, S, Uher, R, Pirlo, K, Weale, ME, Schosser, A, Paredes, UM, Rivera, M, Craddock, N, Owen, MJ, Jones, L, Jones, I, Korszun, A, Aitchison, KJ, Shi, J, Quinn, JP, MacKenzie, A, Vollenweider, P, Waeber, G, Heath, S, Lathrop, M, Muglia, P, Barnes, MR, Whittaker, JC, Tozzi, F, Holsboer, F, Preisig, M, Farmer, AE, Breen, G, Craig, IW and McGuffin, P (2010) Genome-wide association study of major recurrent depression in the U.K. population. The American Journal of Psychiatry 167(8), 949–957. doi: 10.1176/appi.ajp.2010.09091380.CrossRefGoogle ScholarPubMed
Li, Z, Zhang, Y, Wang, Z, Chen, J, Fan, J, Guan, Y, Zhang, C, Yuan, C, Hong, W, Wang, Y, Wu, Z, Huang, J, Hu, Y, Cao, L, Yi, Z, Cui, D, Yu, S, Fang, Y (2013) The role of BDNF, NTRK2 gene and their interaction in development of treatment-resistant depression: data from multicenter, prospective, longitudinal clinic practice. Journal of Psychiatric Research 47(1), 8–14. doi: 10.1016/j.jpsychires.2012.10.003.CrossRefGoogle ScholarPubMed
Licinio, J, Dong, C and Wong, M-L (2009) Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response. Archives of General Psychiatry 66(5), 488. doi: 10.1001/archgenpsychiatry.2009.38.CrossRefGoogle ScholarPubMed
Lin, L, Fu, X, Zhou, X-F, Liu, D, Bobrovskaya, L and Zhou, L (2021) Analysis of blood mature BDNF and proBDNF in mood disorders with specific ELISA assays. Journal of Psychiatric Research 133(3), 166–173. doi: 10.1016/j.jpsychires.2020.12.021.CrossRefGoogle ScholarPubMed
Lisiecka, DM, O’Hanlon, E, Fagan, AJ, Carballedo, A, Morris, D, Suckling, J and Frodl, T (2015) BDNF Val66Met polymorphism in patterns of neural activation in individuals with MDD and healthy controls. Journal of Affective Disorders 184(609–620), 239–244. doi: 10.1016/j.jad.2015.06.002.CrossRefGoogle ScholarPubMed
Liu, X, Xu, Y, Jiang, S, Cui, D, Qian, Y and Jiang, K (2009) Family-based association study between brain-derived neurotrophic factor gene and major depressive disorder of Chinese descent. Psychiatry Research 169(2), 169–172. doi: 10.1016/j.psychres.2008.06.014.CrossRefGoogle ScholarPubMed
Liu, Y, Ho, RC-M and Mak, A (2012) Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. Journal of Affective Disorders 139(3), 230–239. doi: 10.1016/j.jad.2011.08.003.CrossRefGoogle ScholarPubMed
López-León, S, Janssens, AC, González-Zuloeta Ladd, AM, Del-Favero, J, Claes, SJ, Oostra, BA and van Duijn, CM (2008) Meta-analyses of genetic studies on major depressive disorder. Molecular Psychiatry 13(8), 772–785. doi: 10.1038/sj.mp.4002088.CrossRefGoogle ScholarPubMed
Losenkov, IS, Mulder, N, Levchuk, LA, Vyalova, NM, Loonen, A, Bosker, FJ, Simutkin, GG, Boiko, AS, Bokhan, NA, Wilffert, B, Hak, E, Schmidt, AF, Ivanova, SA (2020) Association between BDNF gene variant Rs6265 and the severity of depression in antidepressant treatment-free depressed patients. Frontiers in Psychiatry 11, 38. doi: 10.3389/fpsyt.2020.00038.CrossRefGoogle ScholarPubMed
Maciukiewicz, M, Marshe, VS, Tiwari, AK, Fonseka, TM, Freeman, N, Rotzinger, S, Foster, JA, Kennedy, JL, Kennedy, SH, Müller, DJ (2015) Genetic variation in IL-1β, IL-2, IL-6, TSPO and BDNF and response to duloxetine or placebo treatment in major depressive disorder. Pharmacogenomics 16(17), 1919–1929. doi: 10.2217/pgs.15.136,CrossRefGoogle ScholarPubMed
Maffioletti, E, Gennarelli, M, Gainelli, G, Bocchio-Chiavetto, L, Bortolomasi, M and Minelli, A (2019) BDNF genotype and baseline serum levels in relation to electroconvulsive therapy effectiveness in treatment-resistant depressed patients. The Journal of ECT 35(3), 189–194. doi: 10.1097/yct.0000000000000583,CrossRefGoogle ScholarPubMed
Martin, S, Colle, R, El Asmar, K, Rigal, A, Vievard, A, Feve, B, Becquemont, L, Verstuyft, C and Corruble, E (2019) HOMA-IR increase after antidepressant treatment in depressed patients with the Met allele of the Val66Met BDNF genetic polymorphism. Psychological Medicine 49(14), 2364–2369. doi: 10.1017/S0033291718003240.CrossRefGoogle ScholarPubMed
Matrisciano, F, Bonaccorso, S, Ricciardi, A, Scaccianoce, S, Panaccione, I, Wang, L, Ruberto, A, Tatarelli, R, Nicoletti, F, Girardi, P, Shelton, RC (2009) Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine. Journal of Psychiatric Research 43(3), 247–254. doi: 10.1016/j.jpsychires.2008.03.014.CrossRefGoogle ScholarPubMed
McGuinness, LA and Higgins, J (2021) Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Research Synthesis Methods 12(1), 55–61. doi: 10.1002/jrsm.1411.CrossRefGoogle Scholar
Michaelsen, K, Zagrebelsky, M, Berndt-Huch, J, Polack, M, Buschler, A, Sendtner, M and Korte, M (2010) Neurotrophin receptors TrkB.T1 and p75NTR cooperate in modulating both functional and structural plasticity in mature hippocampal neurons: role of T1 and p75 in processes of plasticity. European Journal of Neuroscience 32(11), 1854–1865. doi: 10.1111/j.1460-9568.2010.07460.x.CrossRefGoogle Scholar
Moher, D, Liberati, A, Tetzlaff, J, Altman, DG, The PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Medicine 6(7), e1000097. doi: 10.1371/journal.pmed.1000097.CrossRefGoogle ScholarPubMed
Molendijk, ML, Spinhoven, P, Polak, M, Bus, BAA, Penninx, BWJH and Elzinga, BM (2014) Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484). Molecular Psychiatry 19(7), 791–800. doi: 10.1038/mp.2013.105.CrossRefGoogle ScholarPubMed
Murphy, ML, Carballedo, A, Fagan, AJ, Morris, D, Fahey, C, Meaney, J and Frodl, T (2012) Neurotrophic tyrosine kinase polymorphism impacts white matter connections in patients with major depressive disorder. Biological Psychiatry 72(8), 663–670. doi: 10.1016/j.biopsych.2012.04.015.CrossRefGoogle ScholarPubMed
National Center for Biotechnology Information (NCBI), BDNF brain derived neurotrophic factor [Homo sapiens (human)], Accessed 8 Oct 2020, https://www.ncbi.nlm.nih.gov/gene/627.Google Scholar
Nestler, EJ, Hyman, SE, Holtzman, DM and Malenka, RC (2015) Atypical Neurotransmitters, Molecular Neuropharmacology: A Foundation for Clinical Neuroscience, Vol. 3e (1–Book, Section), McGraw-Hill Education, https://neurology.mhmedical.com/content.aspx?aid=1105915890 Google Scholar
Neto, FL, Borges, G, Torres-Sanchez, S, Mico, JA and Berrocoso, E (2011) Neurotrophins role in depression neurobiology: a review of basic and clinical evidence. Current Neuropharmacology 9(4), 530–552. doi: 10.2174/157015911798376262.CrossRefGoogle ScholarPubMed
Nibuya, M, Morinobu, S and Duman, R (1995) Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. The Journal of Neuroscience 15(11), 7539–7547. doi: 10.1523/JNEUROSCI.15-11-07539.1995.CrossRefGoogle ScholarPubMed
Numakawa, T, Odaka, H and Adachi, N (2018) Actions of brain-derived neurotrophin factor in the neurogenesis and neuronal function, and its involvement in the pathophysiology of brain diseases. International Journal of Molecular Sciences 19(11), 3650. doi: 10.3390/ijms19113650.CrossRefGoogle ScholarPubMed
Otte, C, Gold, SM, Penninx, BW, Pariante, CM, Etkin, A, Fava, M, Mohr, DC and Schatzberg, AF (2016) Major depressive disorder. Nature Reviews Disease Primers 2(1), 16065. doi: 10.1038/nrdp.2016.65.CrossRefGoogle ScholarPubMed
Oxford Centre for Evidence-Based Medicine (OCEBM) (2009) Levels of Evidence, Accessed 4th May 2020 Available at https://www.cebm.ox.ac.uk/resources/levels-of-evidence/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march-2009.Google Scholar
Oxford Centre for Evidence-Based Medicine (OCEBM) (2011) Levels of Evidence, Accessed 7th August 2022 Available at https://www.cebm.ox.ac.uk/resources/levels-of-evidence/ocebm-levels-of-evidence.Google Scholar
Oz, MD, Baskak, B, Uckun, Z, Artun, NY, Ozdemir, H, Ozel, TK, Ozguven, HD and Suzen, HS (2020) Association between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients. Pharmacogenomics Journal 20(3), 443–450. doi: 10.1038/s41397-019-0127-8.CrossRefGoogle ScholarPubMed
Pae, C-U, Chiesa, A, Porcelli, S, Han, C, Patkar, AA, Lee, S-J, Park, MH, Serretti, A and De Ronchi, D (2012) Influence of BDNF variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia. Neuropsychobiology 65(1), 1–11. doi: 10.1159/000327605.CrossRefGoogle ScholarPubMed
Pampallona, S, Bollini, P, Tibaldi, G, Kupelnick, B and Munizza, C (2004) Combined pharmacotherapy and psychological treatment for depression: a systematic review. Archives of General Psychiatry 61(7), 714. doi: 10.1001/archpsyc.61.7.714.CrossRefGoogle ScholarPubMed
Perroud, N, Aitchison, KJ, Uher, R, Smith, R, Huezo-Diaz, P, Marusic, A, Maier, W, Mors, O, Placentino, A, Henigsberg, N, Rietschel, M, Hauser, J, Souery, D, Kapelski, P, Bonvicini, C, Zobel, A, Jorgensen, L, Petrovic, A, Kalember, P, Schulze, TG, Gupta, B, Gray, J, Lewis, CM, Farmer, AE, McGuffin, P and Craig, I (2009) Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP Project. Neuropsychopharmacology 34(12), 2517–2528. doi: 10.1038/npp.2009.81.CrossRefGoogle ScholarPubMed
Peters, RB, Xavier, J, Mondin, TC, Cardoso, Tde A, Ferreira, FB, Teixeira, L, Gräeff, K, Quevedo, Lde A, Jansen, K, Souza, LD, Oses, JP, Pinheiro, RT, da Silva, RA, Ghisleni, G (2021) BDNF Val66Met polymorphism and resilience in major depressive disorder: the impact of cognitive psychotherapy. Brazilian Journal of Psychiatry 43(1), 22–28. doi: 10.1590/1516-4446-2019-0726.CrossRefGoogle ScholarPubMed
Phillips, JL, Batten, LA, Tremblay, P, Aldosary, F, Du, L and Blier, P (2015) Impact of monoamine-related gene polymorphisms on hippocampal volume in treatment-resistant depression. Acta Neuropsychiatrica 27(6), 353–361. doi: 10.1017/neu.2015.25.CrossRefGoogle ScholarPubMed
Pivac, N, Kim, B, Nedić, G, Joo, YH, Kozarić-Kovačić, D, Hong, JP and Muck-Seler, D (2009) Ethnic differences in brain-derived neurotrophic factor Val66Met polymorphism in Croatian and Korean healthy participants. Croatian Medical Journal 50(1), 43–48. doi: 10.3325/cmj.2009.50.43.CrossRefGoogle ScholarPubMed
Polyakova, M, Stuke, K, Schuemberg, K, Mueller, K, Schoenknecht, P and Schroeter, ML (2015) BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis. Journal of Affective Disorders 174(7), 432–440. doi: 10.1016/j.jad.2014.11.044.CrossRefGoogle ScholarPubMed
Post, RM (2007) Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications. Journal of Psychiatric Research 41(12), 979–990. doi: 10.1016/j.jpsychires.2006.09.009.CrossRefGoogle ScholarPubMed
Pulay, AJ and Réthelyi, JM (2016) Multimarker analysis suggests the involvement of BDNF signaling and microRNA biosynthesis in suicidal behavior. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 171(6), 763–776. doi: 10.1002/ajmg.b.32433.CrossRefGoogle ScholarPubMed
Rahman, MS, Millischer, V, Zeebari, Z, Forsell, Y and Lavebratt, C (2017) BDNF Val66Met and childhood adversity on response to physical exercise and internet-based cognitive behavioural therapy in depressed Swedish adults. Journal of Psychiatric Research 93, 50–58. doi: 10.1016/j.jpsychires.2017.05.007.CrossRefGoogle ScholarPubMed
Rajewska-Rager, A, Skibińska, M, Szczepankiewicz, A, Kapelski, P, Dmitrzak-Weglarz, M, Leszczyńska-Rodziewicz, A and Hauser, J (2008) [Association between polymorphisms of Val66Met in the BDNF gene and the response to escitalopram and nortriptyline treatment in the light of the neurodevelopmental hypothesis of depression]. Psychiatria Polska 42(6), 915–923.Google ScholarPubMed
Ramesh, V, Venkatesan, V, Chellathai, D and Silamban, S (2021) Association of serum biomarker levels and BDNF gene polymorphism with response to selective serotonin reuptake inhibitors in Indian patients with major depressive disorder. Neuropsychobiology 80(3), 201–213. doi: 10.1159/000507371.CrossRefGoogle ScholarPubMed
Ribeiro, L, Busnello, JV, Cantor, RM, Whelan, F, Whittaker, P, Deloukas, P, Wong, M-L and Licinio, J (2007) The brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism and depression in Mexican-Americans. NeuroReport 18(12), 1291–1293. doi: 10.1097/WNR.0b013e328273bcb0.CrossRefGoogle ScholarPubMed
Rimay, T, Benak, I, Kiss, E, Baji, I, Feher, A, Juhasz, A, Strauss, J, Kennedy, J, Barr, C, Kovacs, M, Vetro, A, Kapornai, K (2015) BDNF Val66Met polymorphism and stressful life events in melancholic childhood-onset depression. Psychiatric Genetics 25(6), 249–255. doi: 10.1097/YPG.0000000000000107.CrossRefGoogle ScholarPubMed
Ryan, KM, Dunne, R and McLoughlin, DM (2018) BDNF plasma levels and genotype in depression and the response to electroconvulsive therapy. Brain Stimulation 11(5), 1123–1131. doi: 10.1016/j.brs.2018.05.011.CrossRefGoogle ScholarPubMed
Salvadore, G, Singh, J, Xi, L, Kolb, H, Favis, R, Van Nueten, L and Drevets, W (2015) Impact of the val66met polymorphism of brain-derived neurotrophic factor on esketamine and ketamine antidepressant effects in patients with treatment-resistant depression. In: 9 SUPPL. 1. Presented at the 70th Annual Scientific Convention and Meeting of the Society of Biological Psychiatry, SOBP 2015, Toronto, ON Canada. Biological Psychiatry, Toronto, ON, Canada, pp. 306S. https://www.cochranelibrary.com/central/doi/10.1002/central/CN-01099806/full.Google Scholar
Sarchiapone, M, Carli, V, Roy, A, Iacoviello, L, Cuomo, C, Latella, MC, di Giannantonio, M, Janiri, L, de Gaetano, M, Janal, MN (2008) Association of polymorphism (Val66Met) of brain-derived neurotrophic factor with suicide attempts in depressed patients. Neuropsychobiology 57(3), 139–145. doi: 10.1159/000142361.CrossRefGoogle ScholarPubMed
Sasi, M, Vignoli, B, Canossa, M and Blum, R (2017) Erratum to: Neurobiology of local and intercellular BDNF signaling. Pflügers Archiv - European Journal of Physiology 469(5-6), 611–611. doi: 10.1007/s00424-017-1971-5.CrossRefGoogle ScholarPubMed
Schenkel, LC, Segal, J, Becker, JA, Manfro, GG, Bianchin, MM and Leistner-Segal, S (2010) The BDNF Val66Met polymorphism is an independent risk factor for high lethality in suicide attempts of depressed patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry 34(6), 940–944. doi: 10.1016/j.pnpbp.2010.04.023.CrossRefGoogle ScholarPubMed
Schosser, A, Carlberg, L, Calati, R, Serretti, A, Massat, I, Spindelegger, C, Linotte, S, Mendlewicz, J, Souery, D, Zohar, J, Montgomery, S, Kasper, S (2017) The impact of BDNF polymorphisms on suicidality in treatment-resistant major depressive disorder: a European multicenter study. International Journal of Neuropsychopharmacology 20(10), 782–787. doi: 10.1093/ijnp/pyx028.CrossRefGoogle ScholarPubMed
Schule, C, Zill, P, Baghai, T, Eser, D, Zwanzger, P, Wenig, N, Rupprecht, R and Bondy, B (2006) Brain-derived neurotrophic factor Val66Met polymorphism and dexamethasone/CRH test results in depressed patients. Psychoneuroendocrinology 31(8), 1019–1025. doi: 10.1016/j.psyneuen.2006.06.002.CrossRefGoogle ScholarPubMed
Schröter, K, Brum, M, Brunkhorst-Kanaan, N, Tole, F, Ziegler, C, Domschke, K, Reif, A and Kittel-Schneider, S (2020) Longitudinal multi-level biomarker analysis of BDNF in major depression and bipolar disorder. European archives of psychiatry and clinical neuroscience 270(2), 169–181. doi: 10.1007/s00406-019-01007-y.CrossRefGoogle ScholarPubMed
Sen, S, Duman, R and Sanacora, G (2008) Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biological Psychiatry 64(6), 527–532. doi: 10.1016/j.biopsych.2008.05.005.CrossRefGoogle ScholarPubMed
Shen, Z, Lu, Y, Jiang, H, Ye, J, Zhou, C, He, M, Li, N, Xu, X and Cheng, Y (2020) Brain-derived neurotrophic factor Val66Met polymorphism affects cortical thickness of rostral anterior cingulate in patients with major depressive disorder. NeuroReport 31(16), 1146–1153. doi: 10.1097/WNR.0000000000001528.CrossRefGoogle ScholarPubMed
Shi, Y, Luan, D, Song, R and Zhang, Z (2020) Value of peripheral neurotrophin levels for the diagnosis of depression and response to treatment: a systematic review and meta-analysis. European Neuropsychopharmacology 41(3), 40–51. doi: 10.1016/j.euroneuro.2020.09.633.CrossRefGoogle ScholarPubMed
Shimizu, E, Hashimoto, K and Iyo, M (2004) Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: the possibility to explain ethnic mental traits. American Journal of Medical Genetics 126B(1), 122–123. doi: 10.1002/ajmg.b.20118.CrossRefGoogle ScholarPubMed
Song, Y, Miyaki, K, Suzuki, T, Sasaki, Y, Tsutsumi, A, Kawakami, N, Shimazu, A, Takahashi, M, Inoue, A, Kan, C, Kurioka, S, Shimbo, T (2014) Altered DNA methylation status of human brain derived neurotrophis factor gene could be useful as biomarker of depression. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 165(4), 357–364. doi: 10.1002/ajmg.b.32238.CrossRefGoogle Scholar
Sterne, JAC, Hernán, MA, Reeves, BC, Savović, J, Berkman, ND, Viswanathan, M, Henry, D, Altman, DG, Ansari, MT, Boutron, I, Carpenter, JR, Chan, A-W, Churchill, R, Deeks, JJ, Hróbjartsson, Aørn, Kirkham, J, Jüni, P, Loke, YK, Pigott, TD, Ramsay, CR, Regidor, D, Rothstein, HR, Sandhu, L, Santaguida, PL, Schünemann, HJ, Shea, B, Shrier, I, Tugwell, P, Turner, L, Valentine, JC, Waddington, H, Waters, E, Wells, GA, Whiting, PF and Higgins, JPT (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ (Clinical Research ed.) 355, i4919. doi: 10.1136/bmj.i4919.Google ScholarPubMed
Suchanek, R, Owczarek, A, Kowalczyk, M, Kucia, K and Kowalski, J (2011) Association between C-281A and Val66met functional polymorphisms of BDNF gene and risk of recurrent major depressive disorder in polish population. Journal of Molecular Neuroscience 43(3), 524–530. doi: 10.1007/s12031-010-9478-y.CrossRefGoogle ScholarPubMed
Sullivan, PF, de Geus, EJ, Willemsen, G, James, MR, Smit, JH, Zandbelt, T, Arolt, V, Baune, BT, Blackwood, D, Cichon, S, Coventry, WL, Domschke, K, Farmer, A, Fava, M, Gordon, SD, He, Q, Heath, AC, Heutink, P, Holsboer, F, Hoogendijk, WJ, Hottenga, JJ, Hu, Y, Kohli, M, Lin, D, Lucae, S, Macintyre, DJ, Maier, W, McGhee, KA, McGuffin, P, Montgomery, GW, Muir, WJ, Nolen, WA, Nöthen, MM, Perlis, RH, Pirlo, K, Posthuma, D, Rietschel, M, Rizzu, P, Schosser, A, Smit, AB, Smoller, JW, Tzeng, JY, van Dyck, R, Verhage, M, Zitman, FG, Martin, NG, Wray, NR, Boomsma, DI and Penninx, BW (2009) Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. Molecular Psychiatry 14(4), 359–375. doi: 10.1038/mp.2008.125.CrossRefGoogle ScholarPubMed
Sun, N, Yang, C-X, Liu, Z-F, Li, X-R, Xu, Y and Zhang, K-R (2016) Effects of polymorphisms of serotonin transporter promoter (5-HTTLPR) and brain derived neurotrophic factor gene (G196A rs6265) on the risk of major depressive disorder in the Chinese Han population. European Review for Medical and Pharmacological Sciences 20(9), 1852–1859.Google ScholarPubMed
Taylor, WD, McQuoid, DR, Ashley-Koch, A, MacFall, JR, Bridgers, J, Krishnan, RR and Steffens, DC (2011) BDNF Val66Met genotype and 6-month remission rates in late-life depression. The Pharmacogenomics Journal 11(2), 146–154. doi: 10.1038/tpj.2010.12.CrossRefGoogle ScholarPubMed
Taylor, WD, Zhao, Z, Ashley-Koch, A, Payne, ME, Steffens, DC, Krishnan, RR, Hauser, E and MacFall, JR (2013) Fiber tract-specific white matter lesion severity findings in late-life depression and by AGTR1 A1166C genotype. Human Brain Mapping 34(2), 295–303. doi: 10.1002/hbm.21445.CrossRefGoogle ScholarPubMed
Terracciano, A, Piras, MG, Lobina, M, Mulas, A, Meirelles, O, Sutin, AR, Chan, W, Sanna, S, Uda, M, Crisponi, L, Schlessinger, D (2013) Genetics of serum BDNF: meta-analysis of the Val66Met and genome-wide association study. The World Journal of Biological Psychiatry 14(8), 583–589. doi: 10.3109/15622975.2011.616533.CrossRefGoogle ScholarPubMed
Terrin, N, Schmid, CH and Lau, J (2005) In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias. Journal of Clinical Epidemiology 58(9), 894–901. doi: 10.1016/j.jclinepi.2005.01.006.CrossRefGoogle Scholar
Thoenen, H (1995) Neurotrophins and neuronal plasticity. Science 270(5236), 593–598. doi: 10.1126/science.270.5236.593.CrossRefGoogle ScholarPubMed
Troubat, R, Barone, P, Leman, S, Desmidt, T, Cressant, A, Atanasova, B, Brizard, B, El Hage, W, Surget, A, Belzung, C, Camus, V (2021) Neuroinflammation and depression: a review. European Journal of Neuroscience 53(1), 151–171. doi: 10.1111/ejn.14720.CrossRefGoogle ScholarPubMed
Tsai, S-J, Cheng, C-Y, Yu, YW-Y, Chen, T-J and Hong, C-J (2003) Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response. American Journal of Medical Genetics 123B(1), 19–22. doi: 10.1002/ajmg.b.20026.CrossRefGoogle ScholarPubMed
Tsuchimine, S, Yasui-Furukori, N, Nakagami, T, Sato, Y and Kaneko, S (2012) DRD3, but not BDNF, genotype affects treatment response to paroxetine in major depressive disorder: a preliminary study. Journal of Clinical Psychopharmacology 32(5), 724–726. doi: 10.1097/JCP.0b013e318267b6da.CrossRefGoogle Scholar
van Praag, HM (2004) Can stress cause depression? Progress in Neuro-Psychopharmacology and Biological Psychiatry 28(5), 891–907. doi: 10.1016/j.pnpbp.2004.05.031.CrossRefGoogle ScholarPubMed
van Velzen, LS, Schmaal, L, Jansen, R, Milaneschi, Y, Opmeer, EM, Elzinga, BM, van der Wee, NJA, Veltman, DJ and Penninx, BWJH (2016) Effect of childhood maltreatment and brain-derived neurotrophic factor on brain morphology. Social Cognitive and Affective Neuroscience 11(11), 1841–1852. doi: 10.1093/scan/nsw086.CrossRefGoogle ScholarPubMed
Verhagen, M, van der Meij, A, van Deurzen, PAM, Janzing, JGE, Arias-Vásquez, A, Buitelaar, JK and Franke, B (2010) Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity. Molecular Psychiatry 15(3), 260–271. doi: 10.1038/mp.2008.109.CrossRefGoogle ScholarPubMed
Vicario-Abejón, C, Owens, D, McKay, R and Segal, M (2002) Role of neurotrophins in central synapse formation and stabilization. Nature Reviews Neuroscience 3(12), 965–974. doi: 10.1038/nrn988.CrossRefGoogle ScholarPubMed
Videbech, P (2004) Hippocampal volume and depression: a meta-analysis of MRI studies. American Journal of Psychiatry 161(11), 1957–1966. doi: 10.1176/appi.ajp.161.11.1957.CrossRefGoogle ScholarPubMed
Voegeli, G, Ramoz, N, Shekhtman, T, Courtet, P, Gorwood, P and Kelsoe, JR (2016) Neurotrophin genes and antidepressant-worsening suicidal ideation: a prospective case-control study. The International Journal of Neuropsychopharmacology 19(11), pyw059. doi: 10.1093/ijnp/pyw059.CrossRefGoogle ScholarPubMed
Wang, X-C, Xu, D-J, Chen, G-H, Xia, Q and Liu, L-N (2014) Association of 2 neurotrophic factor polymorphisms with efficacy of paroxetine in patients with major depressive disorder in a Chinese population. Therapeutic Drug Monitoring 36(5), 612–617. doi: 10.1097/FTD.0000000000000062.CrossRefGoogle ScholarPubMed
Wilkinson, ST and Sanacora, G (2016) Ketamine: a potential rapid-acting antisuicidal agent? Review: effects of ketamine on suicidal ideation. Depression and Anxiety 33(8), 711–717. doi: 10.1002/da.22498.CrossRefGoogle Scholar
Xiao, Z, Liu, W, Gao, K, Wan, Q, Yang, C, Wang, H, Wang, X, Wang, G and Liu, Z (2011) Interaction between CRHR1 and BDNF genes increases the risk of recurrent major depressive disorder in chinese population. PLoS ONE 6(12), e28733. doi: 10.1371/journal.pone.0028733.CrossRefGoogle ScholarPubMed
Xu, G, Lin, K, Rao, D, Dang, Y, Ouyang, H, Mai, G and Zhang, M (2012) Brain-derived neurotrophic factor gene polymorphism (Val66Met) and the early response to antidepressant in Chinese Han population. Psychiatric Genetics 22(4), 214–215. doi: 10.1097/YPG.0b013e32834c0c87.CrossRefGoogle ScholarPubMed
Yan, T, Wang, L, Kuang, W, Xu, J, Li, S, Chen, J and Yang, Y (2014) Brain-derived neurotrophic factor Val66Met polymorphism association with antidepressant efficacy: a systematic review and meta-analysis: BDNF Val66Met and antidepressant efficacy. Asia-Pacific Psychiatry 6(3), 241–251. doi: 10.1111/appy.12148.CrossRefGoogle ScholarPubMed
Yang, C, Sun, N, Liu, Z, Li, X, Xu, Y and Zhang, K (2016) The interaction of combined effects of the BDNF and PRKCG genes and negative life events in major depressive disorder. Psychiatry Research 237, 72–77. doi: 10.1016/j.psychres.2016.01.076.CrossRefGoogle ScholarPubMed
Yeebo, MF (2015) Ethnic differences in BDNF Val66Met polymorphism. British Journal of Psychiatry 207(4), 363–363. doi: 10.1192/bjp.207.4.363.CrossRefGoogle ScholarPubMed
Youssef, MM, Underwood, MD, Huang, Y-Y, Hsiung, S, Liu, Y, Simpson, NR, Bakalian, MJ, Rosoklija, GB, Dwork, AJ, Arango, V, Mann, JJ (2018) Association of BDNF Val66Met polymorphism and brain BDNF levels with major depression and suicide. International Journal of Neuropsychopharmacology 21(6), 528–538. doi: 10.1093/ijnp/pyy008.CrossRefGoogle ScholarPubMed
Zhang, C, Ran, L, Ai, M, Wang, W, Chen, J, Wu, T, Liu, W, Jin, J, Wang, S, Kuang, L (2020a) Targeted sequencing of the BDNF gene in young Chinese Han people with major depressive disorder. Molecular Genetics & Genomic Medicine 8(10), e1484. doi: 10.1002/mgg3.1484.CrossRefGoogle ScholarPubMed
Zhang, H, Li, X, Pang, J, Zhao, X, Cao, S, Wang, X, Wang, X and Li, H (2020b) Predicting SSRI-resistance: clinical features and tagSNPs prediction models based on support vector machine. Frontiers in Psychiatry 11, 493. doi: 10.3389/fpsyt.2020.00493.CrossRefGoogle ScholarPubMed
Zhang, K, Yang, C, Xu, Y, Sun, N, Yang, H, Liu, J, Xu, Q and Shen, Y (2010) Genetic association of the interaction between the BDNF and GSK3B genes and major depressive disorder in a Chinese population. Journal of Neural Transmission 117(3), 393–401. doi: 10.1007/s00702-009-0360-4.CrossRefGoogle ScholarPubMed
Zhao, G, Zhang, C, Chen, J, Su, Y, Zhou, R, Wang, F, Xia, W, Huang, J, Wang, Z, Hu, Y, Cao, L, Guo, X, Yuan, C, Wang, Y, Yi, Z, Lu, W, Wu, Y, Wu, Z, Hong, W, Peng, D and Fang, Y (2017) Ratio of mBDNF to proBDNF for differential diagnosis of major depressive disorder and bipolar depression. Molecular Neurobiology 54(7), 5573–5582. doi: 10.1007/s12035-016-0098-6.CrossRefGoogle ScholarPubMed
Zhao, M, Chen, L, Yang, J, Han, D, Fang, D, Qiu, X, Yang, X, Qiao, Z, Ma, J, Wang, L, Jiang, S, Song, X, Zhou, J, Zhang, J, Chen, M, Qi, D, Yang, Y, Pan, H (2018) BDNF Val66Met polymorphism, life stress and depression: a meta-analysis of gene-environment interaction. Journal of Affective Disorders 227(Suppl. 1), 226–235. doi: 10.1016/j.jad.2017.10.024.CrossRefGoogle ScholarPubMed
Zou, Y-F, Wang, Y, Liu, P, Feng, X-L, Wang, B-Y, Zang, T-H, Yu, X, Wei, J, Liu, Z-C, Liu, Y, Tao, M, Li, H-C, Li, K-Q, Hu, J, Li, M, Zhang, K-R, Ye, D-Q, Xu, X-P (2010a) Association of brain-derived neurotrophic factor genetic val66met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in Chinese major depressive patients. Neuropsychobiology 61(2), 71–78. doi: 10.1159/000265132.CrossRefGoogle ScholarPubMed
Zou, Y-F, Ye, D-Q, Feng, X-L, Su, H, Pan, F-M and Liao, F-F (2010b) Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder. European Neuropsychopharmacology 20(8), 535–544. doi: 10.1016/j.euroneuro.2009.12.005.CrossRefGoogle ScholarPubMed
Supplementary material: Image

Hartig and Nemeş supplementary material

Hartig and Nemeş supplementary material 1

Download Hartig and Nemeş supplementary material(Image)
Image 6.7 MB
Supplementary material: File

Hartig and Nemeş supplementary material

Hartig and Nemeş supplementary material 2

Download Hartig and Nemeş supplementary material(File)
File 23 KB
Supplementary material: File

Hartig and Nemeş supplementary material

Hartig and Nemeş supplementary material 3

Download Hartig and Nemeş supplementary material(File)
File 22.4 KB
Supplementary material: File

Hartig and Nemeş supplementary material

Hartig and Nemeş supplementary material 4

Download Hartig and Nemeş supplementary material(File)
File 32.3 KB